Literature DB >> 23921789

[Antidotes in clinical toxicology].

K Hruby1.   

Abstract

This overview describes antidotes, and their clinical pharmacology, that have an established significance in the currently practiced clinical toxicology because of their proven effectiveness in the treatment of serious poisonings. For the proper, efficient, and targeted use of an antidote, pharmacological knowledge is required, which is a central subject of this article. Current data from the literature are used as reference along with the accumulated experiences about possible adverse effects in order to include them in therapeutic considerations. The dosage of antidotes is the subject of several other review articles and is therefore not included in this synopsis.

Mesh:

Substances:

Year:  2013        PMID: 23921789     DOI: 10.1007/s00063-013-0221-7

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  12 in total

1.  Failure of lipid emulsion to reverse neurotoxicity after an ultrasound-guided axillary block with ropivacaine and mepivacaine.

Authors:  Emile Calenda; Stelian A Dinescu
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

2.  Lipid infusion therapy: translation to clinical practice.

Authors:  Guy L Weinberg
Journal:  Anesth Analg       Date:  2008-05       Impact factor: 5.108

Review 3.  Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose.

Authors:  Guy L Weinberg
Journal:  Anesthesiology       Date:  2012-07       Impact factor: 7.892

4.  Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases.

Authors:  K E Hovda; S Froyshov; H Gudmundsdottir; N Rudberg; D Jacobsen
Journal:  Clin Nephrol       Date:  2005-09       Impact factor: 0.975

5.  Somatostatin inhibits B-cell secretion via a subtype-2 somatostatin receptor in the isolated perfused human pancreas.

Authors:  S Moldovan; A Atiya; T E Adrian; R M Kleinman; K Lloyd; K Olthoff; D Imagawa; L Shevlin; D Coy; J Walsh
Journal:  J Surg Res       Date:  1995-07       Impact factor: 2.192

6.  Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study.

Authors:  Wolfgang Uhl; Arno Nolting; Georg Golor; Karl Ludwig Rost; Andreas Kovar
Journal:  Clin Toxicol (Phila)       Date:  2006       Impact factor: 4.467

7.  Haemodynamic effects of high doses of insulin during acute left ventricular failure in dogs.

Authors:  O Reikerås; P Gunnes; D Sørlie; R Ekroth; R Jorde; O D Mjøs
Journal:  Eur Heart J       Date:  1985-05       Impact factor: 29.983

Review 8.  Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies.

Authors:  Chloé Jamaty; Benoit Bailey; Alexandre Larocque; Eric Notebaert; Karine Sanogo; Jean-Marc Chauny
Journal:  Clin Toxicol (Phila)       Date:  2010-01       Impact factor: 4.467

9.  Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.

Authors:  J A Kline; C A Tomaszewski; J D Schroeder; R M Raymond
Journal:  J Pharmacol Exp Ther       Date:  1993-11       Impact factor: 4.030

10.  High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock.

Authors:  Joel S Holger; Samuel J Stellpflug; Jon B Cole; Carson R Harris; Kristin M Engebretsen
Journal:  Clin Toxicol (Phila)       Date:  2011-08-08       Impact factor: 4.467

View more
  2 in total

1.  [Acute poisoning in adults].

Authors:  L Weidhase; H Hentschel; L Mende; G Schulze; S Petros
Journal:  Internist (Berl)       Date:  2014-03       Impact factor: 0.743

2.  [Cardiogenic shock after drug therapy for atrial fibrillation with tachycardia : Case report of an 89-year-old woman].

Authors:  H Fey; M Jost; A T Geise; T Bertsch; M Christ
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-10-06       Impact factor: 0.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.